Over the last 7 days, the Life Sciences industry has dropped 1.1%, driven by ST PharmLtd declining 5.4%. However, the industry is down 4.2% over the past year. As for the next few years, earnings are expected to grow by 19% per annum.
Has the South Korean Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 27 Jan 2023 | ₩62.1t | ₩3.5t | ₩426.6b | 20.5x | 145.5x | 17.8x |
Sun, 25 Dec 2022 | ₩63.0t | ₩3.4t | ₩428.7b | 21.3x | 146.9x | 18.3x |
Tue, 22 Nov 2022 | ₩68.9t | ₩3.4t | ₩440.9b | 22.9x | 156.2x | 20.3x |
Thu, 20 Oct 2022 | ₩65.7t | ₩3.0t | ₩448.5b | 23.4x | 146.4x | 22x |
Sat, 17 Sep 2022 | ₩63.0t | ₩3.0t | ₩448.5b | 28.5x | 140.4x | 21.1x |
Mon, 15 Aug 2022 | ₩71.9t | ₩2.7t | ₩454.7b | 28.3x | 158.2x | 26.5x |
Wed, 13 Jul 2022 | ₩66.1t | ₩2.7t | ₩454.7b | 27.1x | 145.4x | 24.4x |
Fri, 10 Jun 2022 | ₩66.5t | ₩2.7t | ₩454.1b | 27x | 146.5x | 24.6x |
Sun, 08 May 2022 | ₩63.0t | ₩2.4t | ₩379.4b | 23.1x | 166x | 26x |
Tue, 05 Apr 2022 | ₩60.8t | ₩2.4t | ₩379.4b | 25.6x | 160.2x | 25.1x |
Thu, 03 Mar 2022 | ₩57.4t | ₩2.4t | ₩409.6b | 25.4x | 140.1x | 24.4x |
Sat, 29 Jan 2022 | ₩55.6t | ₩2.3t | ₩412.7b | 23.7x | 134.7x | 23.7x |
Mon, 27 Dec 2021 | ₩66.5t | ₩2.3t | ₩412.7b | 28.8x | 161.2x | 28.3x |
Wed, 24 Nov 2021 | ₩63.3t | ₩2.3t | ₩403.8b | 24x | 156.8x | 27.4x |
Fri, 22 Oct 2021 | ₩64.3t | ₩2.1t | ₩329.9b | 26.8x | 194.9x | 29.9x |
Sun, 19 Sep 2021 | ₩69.7t | ₩2.1t | ₩329.9b | 31.2x | 211.2x | 32.4x |
Tue, 17 Aug 2021 | ₩75.2t | ₩2.2t | ₩336.8b | 35.5x | 223.2x | 34x |
Tue, 01 Jun 2021 | ₩64.3t | ₩2.1t | ₩247.5b | 38.6x | 259.8x | 30.9x |
Fri, 05 Mar 2021 | ₩57.5t | ₩2.0t | ₩213.0b | 64.8x | 269.9x | 29x |
Mon, 07 Dec 2020 | ₩59.9t | ₩1.8t | ₩306.1b | 59.1x | 195.6x | 32.4x |
Thu, 10 Sep 2020 | ₩59.4t | ₩1.7t | ₩273.1b | 77.8x | 217.6x | 36x |
Wed, 03 Jun 2020 | ₩45.7t | ₩1.4t | ₩209.9b | 76.6x | 217.7x | 32.8x |
Sat, 07 Mar 2020 | ₩34.0t | ₩1.2t | ₩177.8b | 57x | 191.1x | 28x |
198.1x
Which industries have driven the changes within the South Korean Healthcare industry?
KR Market | 3.77% | |
Healthcare | 0.86% | |
Life Sciences | -0.58% | |
Clinical Research and Equipment | -0.58% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
A207940 Samsung BiologicsLtd | ₩809.00k | 1.1% +₩640.6b | 9.5% | PE113.5x | |
A268600 Cellivery Therapeutics | ₩10.09k | 5.9% +₩20.4b | -36.8% | PS17.2x | |
A087010 Peptron | ₩8.39k | 10.4% +₩16.3b | -5.2% | PS29.8x | |
A278650 KNOTUSLtd | ₩4.92k | 3.0% +₩10.2b | 73.5% | PE93.4x | |
A043090 Exergy21 | ₩1.82k | 10.3% +₩8.4b | 29.1% | PS31.5x |